Six notes:
1. Although the orthopedic segment saw a return to growth overall, the recovery was mixed among procedures types.
2. First-quarter hip sales increased 3.2 percent year over year to $357 million.
3. Spine, sports and other sales decreased 2.2 percent to $706 million, and knee sales declined 9.9 percent to $317 million, compared to the first quarter of 2020.
4. The medical device segment, which saw four consecutive quarters of declines in 2020, reported $6.6 billion in first-quarter sales in 2021, representing 8 percent year-over-year growth.
5. The company expects orthopedic sales in the second and third quarters “to be on good trends” based on “surgical planning reports that we saw, especially through the end of first quarter,” CEO Alex Gorsky said in an April 20 earnings call transcribed by The Motley Fool.
6. Johnson & Johnson posted $100 million in first-quarter sales of its COVID-19 vaccine.
More articles on devices:
Former Laser Spine Institute leader named chief of surgery at Florida practice
Late-week spine surgeries linked to longer hospital stays, study finds
Spine spinoff, partial knee robot & more: 6 key Zimmer Biomet developments
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
